lung cancer drug Keytruda

News

NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England.

News

Lilly's retatrutide achieved weight loss of more than 30% at two years in a new trial, firming up its credentials as a next-generation obesity drug.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.